HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
In 2018 alone, an estimated 234,030 people will be diagnosed with lung cancer in the U.S. Unfortunately, many of those cases won’t be caught until the cancer has already progressed to an advanced stage, making treatment much harder. That’s why RCCA is dedicated to making sure people know the early signs and symptoms of lung cancer — especially if you’re a smoker or know someone who is.
If you suspect you might have lung cancer, don’t wait. Make an appointment at your doctor’s office to get your symptoms checked out.
It’s normal for people not to have any signs of lung cancer at first. Also, symptoms are usually the same for both men and women, but every individual is different. For example, one person may experience all of these, while another only has one or two symptoms.
In addition, there are several different types of lung cancer, including the most common, adenocarcinoma. But, in general, the initial symptoms will be the same for all types. Here are some of the most common symptoms of lung cancer:
Be sure to pay close attention to the symptoms if you have an increased risk. You’re more likely to develop lung cancer if any of the following applies to you:
Remember, even non-smokers are still susceptible to lung cancer — especially women.
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.